JENNIFER GIRAUDO: Open Payments
NPI 1245913706 · SALINAS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,144 in 46 payments from 12 companies in 2025. Trend: 2023 $358 · 2024 $1,198 · 2025 $1,144
Food & beverage: $1,084Education: $59
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 12 | $332 |
| GENZYME CORPORATION | 8 | $183 |
| GlaxoSmithKline, LLC. | 5 | $129 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $110 |
| AstraZeneca Pharmaceuticals LP | 4 | $100 |
| Novartis Pharmaceuticals Corporation | 4 | $80 |
| Blueprint Medicines Corporation | 2 | $72 |
| Genentech USA, Inc. | 2 | $45 |
| Incyte Corporation | 2 | $44 |
| Organon LLC | 1 | $21 |
Products named: DUPIXENT, NEFFY, AYVAKIT, NUCALA, TEZSPIRE, TRELEGY ELLIPTA, Xolair, OPZELURA.
Industry payments across CA — which companies pay providers there.
